Mnemo Therapeutics Names Robert LaCaze as Chief Executive Officer

/PRNewswire/ -- Mnemo Therapeutics, a biotechnology company developing next-generation T cell therapies, today announced the appointment of Robert LaCaze as...

Related Keywords

New York ,United States ,Louisiana ,Paris ,France General ,France ,New Jersey ,Alexandria ,Al Iskandariyah ,Egypt ,Mnemo Enfini ,Sloan Kettering ,Institut Curie ,Bristol Myers Squibb ,Bayer Ag ,Linkedin ,Oncology Disease Strategy Team ,Louisiana Tech University ,Global Oncology ,Oncology Disease Strategy ,Louisiana Tech College ,Business Administration Advisory Board ,Louisiana Tech ,With Robert ,Casdin Capital ,Sofinnova Partners ,Emerson Collective ,Alexandria Venture ,Memorial Sloan Kettering ,New York City ,Mnemo Therapeutics ,Health Care Amp Hospitals ,Medical Pharmaceuticals ,Biotechnology ,Personnel Announcements ,